2 unknown, 1 recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Microspheres: new trials by email Literature Review of Microspheres trials Research Report on Microspheres
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC Yttrium [90Y] Microsphere Injection, Conventional transcatheter arterial chemoembolization, Camrelizumab - HCC | Phase 2 | Recruiting | GrandPharma (China) Co., Ltd. | 120 | 2025-08-22 | 2026-01-12 |
| Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization Holmium-166-poly (L-lactic acid) microspheres - Colorectal Neoplasms, Neoplasm Metastasis | Phase 2 / Phase 3 | Unknown | UMC Utrecht | 25 | 2014-11-01 | 2016-11-09 |
| Definitive Therapy for Oligometastatic Solid Malignancies Complete Surgical Removal, Stereotactic Radiosurgery, Ablative external beam radiation dose - Stage IV or Recurrent Carcinoma or Sarcoma | Phase 2 | Unknown | Rocky Mountain Cancer Centers | 110 | 2005-12-01 | 2013-07-15 |
Neoplasm Metastasis (2) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Liver Diseases (1) · Recurrence (1) · Sarcoma (1)
GrandPharma (China) Co., Ltd. (1) · Rocky Mountain Cancer Centers (1) · UMC Utrecht (1)
China (1) · Netherlands (1) · United States (1)
Dennise Carter, MD (1) · Max A Viergever, Prof. dr. ir. (1) · Zhiping Yan, MD (1)